[{"id":5414,"regimens":[{"id":10088,"duration":null,"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":5802,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10088},{"id":5803,"answer":"In a novel combination with another drug","answer_other":"","regimen":10088}],"created":"2020-04-30T01:38:11.297801Z","updated":"2020-05-06T00:20:19.021880Z","dose":null,"frequency":"","route":"","severity":"Inpatient","severity_detail":null,"comments":null,"report":5414},{"id":10089,"duration":null,"drug":{"id":8711,"name":"Levofloxacin","url":"cure-api2.ncats.io/v1/drugs/8711","rxNorm_id":null,"notes":null},"use_drug":[{"id":5804,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10089},{"id":5805,"answer":"In a novel combination with another drug","answer_other":"","regimen":10089}],"created":"2020-04-30T01:38:11.303307Z","updated":"2020-05-06T00:20:19.024565Z","dose":null,"frequency":"","route":"","severity":"Inpatient","severity_detail":null,"comments":null,"report":5414}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7088,"answer":"PCR","answer_other":"","report":5414}],"how_diagnosis":[{"id":11778,"answer":"PCR","answer_other":"","report":5414},{"id":11851,"answer":"Imaging","answer_other":"","report":5414},{"id":11852,"answer":"Clinical assessment","answer_other":"","report":5414}],"author_username":"CURE ID Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1892,"name":"Coronavirus - covid-19"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Undetermined","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3231,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5414}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[],"races":[],"created":"2020-04-30T01:38:11.284260Z","updated":"2020-05-01T19:00:44.147503Z","title":"Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32091386,"doi":"10.3201/eid2605.200198","article_url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=32091386","pub_year":2020,"published_authors":"Tong ZD, Tang A, Li KF, Li P, Wang HL, Yi JP, Zhang YL, Yan JB","article_author_email":"","journal":"Emerging infectious diseases","abstract":"We report a 2-family cluster of persons infected with severe acute respiratory syndrome coronavirus 2 in the city of Zhoushan, Zhejiang Province, China, during January 2020. The infections resulted from contact with an infected but potentially presymptomatic traveler from the city of Wuhan in Hubei Province.","article_type":"","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":false,"outcome":"Outcome is unknown/not yet determined","surgery":"","age":"21-30 years","sex":"Male","ethnicity":null,"country_contracted":"","country_treated":"","began_treatment_year":"","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"NR","pregnant":false,"unknown":false,"site_of_disease":"","clinical_syndrome":"Fever, cough and skin tingling","severity":"Inpatient","prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"","reminder":true,"when_reminder":"2 weeks","additional_info":"Ever on mechanical ventilation (invasive or non-invasive)?: NR\r\nAuthor defined severe?: NR\r\nJustification for author-indicated response: \"Because his cough did not improve, he was hospitalized for further evaluation\"\r\nDay in disease course that symptoms were noted to begin improving: NR\r\nDay in disease course that full resolution of symptoms was noted: NR\r\nDay in disease course that patient was discharged if admitted: NR","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,8711]},{"id":6210,"regimens":[{"id":11873,"duration":{"id":5871,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":8998,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11873},{"id":8999,"answer":"In a novel combination with another drug","answer_other":"","regimen":11873}],"created":"2020-10-07T19:00:35.013812Z","updated":"2020-11-05T18:02:11.831600Z","dose":"500mg","frequency":"q3d","route":"Orally","severity":"Inpatient","severity_detail":"","comments":null,"report":6210},{"id":11874,"duration":{"id":5872,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9560,"name":"Paracetamol","url":"cure-api2.ncats.io/v1/drugs/9560","rxNorm_id":null,"notes":null},"use_drug":[{"id":9000,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11874},{"id":9001,"answer":"In a novel combination with another drug","answer_other":"","regimen":11874}],"created":"2020-10-07T19:00:35.021411Z","updated":"2020-11-05T18:02:11.838296Z","dose":"1g","frequency":"q4d","route":"Orally","severity":"Inpatient","severity_detail":"","comments":null,"report":6210}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8152,"answer":"Clinical assessment","answer_other":"","report":6210}],"how_diagnosis":[{"id":13877,"answer":"Clinical assessment","answer_other":"","report":6210},{"id":13878,"answer":"Imaging","answer_other":"","report":6210},{"id":13879,"answer":"PCR","answer_other":"","report":6210}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4243,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6210},{"id":4244,"answer":"Unusual disease presentation","answer_other":"","report":6210}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":398,"answer":"Black or African American","answer_other":""}],"created":"2020-10-07T18:59:37.265601Z","updated":"2020-11-05T18:02:11.822861Z","title":"Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32371417,"doi":"10.7861/clinmed.2020-0182","article_url":"https://pubmed.ncbi.nlm.nih.gov/32371417/","pub_year":2020,"published_authors":"Wong PF\r\nCraik S\r\nNewman P\r\nMakan A\r\nSrinivasan K\r\nCrawford E\r\nDev D\r\nMoudgil H\r\nAhmad N","article_author_email":"pofung.wong@nhs.net","journal":"Clinical medicine (London, England)","abstract":"A 40 some year-old man developed acute brainstem dysfunction 3 days after hospital admission with symptoms of the novel SARS-CoV-2 infection (COVID-19). Magnetic resonance imaging showed changes in keeping with inflammation of the brainstem and the upper cervical cord, leading to a diagnosis of rhombencephalitis. No other cause explained the patient's abnormal neurological findings. He was managed conservatively with rapid spontaneous improvement in some of his neurological signs and was discharged home with continued neurology follow up.          \r\n        Keywords:      \r\n                  COVID-19; MRI; brainstem encephalitis; hepatitis; rhombencephalitis.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"United Kingdom","country_treated":"United Kingdom","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":true,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Glaucoma","pregnant":false,"unknown":false,"site_of_disease":"Lungs, Brain, Liver","clinical_syndrome":"Pneumonia, Rhombencephalitis, mild bilateral facial weakness, derangement of liver enzymes","severity":"Inpatient","prev_treatment":"","unusual":"A case of rhombencephalitis as a rare complication of acute COVID-19 infection","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"While the patient was still on treatment","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Patient was previously treated for hypertension with ramipril and amoldipine, and treated for Glaucoma with dorzolamide and timolol maleate eye drops.\r\n\r\nThe patient’s neurological symptoms and liver enzymes improved steadily and he was discharged home after 11 days with neurology follow-up. At discharge he was prescribed gabapentin 300 mg twice per day orally with some resulting improvement in his hiccups and nystagmus but oscillopsia and ataxia persisted.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,9560]},{"id":6238,"regimens":[{"id":11960,"duration":{"id":5958,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":9153,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11960},{"id":9154,"answer":"In a novel combination with another drug","answer_other":"","regimen":11960}],"created":"2020-10-09T23:38:49.079295Z","updated":"2020-10-09T23:47:56.634019Z","dose":"","frequency":"","route":"","severity":"Outpatient","severity_detail":"","comments":null,"report":6238},{"id":11961,"duration":{"id":5959,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8986,"name":"Metamizole Sodium","url":"cure-api2.ncats.io/v1/drugs/8986","rxNorm_id":null,"notes":null},"use_drug":[{"id":9155,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11961},{"id":9156,"answer":"In a novel combination with another drug","answer_other":"","regimen":11961}],"created":"2020-10-09T23:38:49.087837Z","updated":"2020-10-09T23:47:56.640423Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6238},{"id":11962,"duration":{"id":5960,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9905,"name":"Prednisolone","url":"cure-api2.ncats.io/v1/drugs/9905","rxNorm_id":null,"notes":null},"use_drug":[{"id":9157,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11962},{"id":9158,"answer":"In a novel combination with another drug","answer_other":"","regimen":11962}],"created":"2020-10-09T23:38:49.094627Z","updated":"2020-10-09T23:47:56.646089Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6238}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8205,"answer":"Clinical assessment","answer_other":"","report":6238},{"id":8206,"answer":"PCR","answer_other":"","report":6238}],"how_diagnosis":[{"id":13949,"answer":"Clinical assessment","answer_other":"","report":6238},{"id":13950,"answer":"PCR","answer_other":"","report":6238}],"author_username":"Belinda Nhundu","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4278,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6238}],"adverse_event_outcome":[{"id":79,"answer":"Hospitalization (initial or prolonged)","report":6238}],"is_author":false,"cross_linked_diseases":[{"id":569,"name":"Vasculitis"}],"races":[{"id":419,"answer":"White","answer_other":""}],"created":"2020-10-09T23:36:44.999060Z","updated":"2020-10-09T23:47:56.626186Z","title":"Drug-induced vasculitis in a patient with COVID-19.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32378770,"doi":"10.1111/jdv.16588","article_url":"https://pubmed.ncbi.nlm.nih.gov/32378770/","pub_year":2020,"published_authors":"Vanegas Ramirez A\r\nEfe D\r\nFischer M","article_author_email":"andreavanegas@web.de","journal":"Journal of the European Academy of Dermatology and Venereology : JEADV","abstract":"A German woman in her 50s with a history of skin reactions to unknown antibiotics, depression and high blood pressure presented with a 2-day history of symmetrically distributed pruritic pink-to-red maculopapular exanthema on the trunk and extremities","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"51-60 years","sex":"Female","ethnicity":"Not Hispanic/Latino","country_contracted":"Germany","country_treated":"Germany","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":true,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":true,"other_comorbid":"Skins reactions to antibiotics","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":true,"adverse_events":"drug-induced vasculitis after taking amoxicillin and metamizole- drugs were discontinued.","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Drug-related skin reaction (vasculitis) in a Covid-19 patient.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,8986,9905]},{"id":6452,"regimens":[{"id":12581,"duration":{"id":6575,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":10436,"answer":"Other","answer_other":"Likely given for bacterial cover","regimen":12581}],"created":"2020-11-13T18:31:59.608650Z","updated":"2020-11-13T22:07:28.533612Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6452},{"id":12582,"duration":{"id":6576,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6772,"name":"Chloroquine","url":"cure-api2.ncats.io/v1/drugs/6772","rxNorm_id":null,"notes":null},"use_drug":[{"id":10373,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12582},{"id":10374,"answer":"In a novel combination with another drug","answer_other":"","regimen":12582}],"created":"2020-11-13T18:31:59.616416Z","updated":"2020-11-13T22:07:28.493232Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6452},{"id":12616,"duration":null,"drug":{"id":9229,"name":"Nadroparin","url":"cure-api2.ncats.io/v1/drugs/9229","rxNorm_id":null,"notes":null},"use_drug":[{"id":10437,"answer":"Other","answer_other":"For thrombosis prophylaxis","regimen":12616}],"created":"2020-11-13T22:07:28.516722Z","updated":"2020-11-13T22:07:28.534481Z","dose":"3800 IU, later increased to 5700 IU","frequency":"daily","route":"SC","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12617,"duration":null,"drug":{"id":11408,"name":"Tissue plasminogen activator","url":"cure-api2.ncats.io/v1/drugs/11408","rxNorm_id":19,"notes":""},"use_drug":[{"id":10438,"answer":"It was not used in a new way","answer_other":"","regimen":12617},{"id":10439,"answer":"Other","answer_other":"For cerebral infarct","regimen":12617}],"created":"2020-11-13T22:07:28.520764Z","updated":"2020-11-13T22:07:28.535344Z","dose":null,"frequency":"","route":"","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12618,"duration":null,"drug":{"id":6964,"name":"Clopidogrel","url":"cure-api2.ncats.io/v1/drugs/6964","rxNorm_id":null,"notes":null},"use_drug":[{"id":10440,"answer":"It was not used in a new way","answer_other":"","regimen":12618},{"id":10441,"answer":"Other","answer_other":"for secondary stroke prevention","regimen":12618}],"created":"2020-11-13T22:07:28.525145Z","updated":"2020-11-13T22:07:28.536171Z","dose":null,"frequency":"","route":"","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12619,"duration":null,"drug":{"id":10749,"name":"Tinzaparin","url":"cure-api2.ncats.io/v1/drugs/10749","rxNorm_id":null,"notes":null},"use_drug":[{"id":10442,"answer":"It was not used in a new way","answer_other":"","regimen":12619},{"id":10443,"answer":"Other","answer_other":"Initiated after PE was diagnosed","regimen":12619}],"created":"2020-11-13T22:07:28.529363Z","updated":"2020-11-13T22:07:28.537078Z","dose":"18,000 IU","frequency":"daily","route":"sc","severity":null,"severity_detail":null,"comments":null,"report":6452}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8480,"answer":"Clinical assessment","answer_other":"","report":6452},{"id":8481,"answer":"Imaging","answer_other":"","report":6452}],"how_diagnosis":[{"id":14493,"answer":"Clinical assessment","answer_other":"","report":6452},{"id":14494,"answer":"PCR","answer_other":"","report":6452},{"id":14520,"answer":"Imaging","answer_other":"","report":6452}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4584,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6452}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-11-13T18:29:40.000455Z","updated":"2020-11-13T22:07:28.479001Z","title":"Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32386986,"doi":"10.1016/j.thromres.2020.04.046","article_url":"https://pubmed.ncbi.nlm.nih.gov/32386986/","pub_year":2020,"published_authors":"Brüggemann R\r\nGietema H\r\nJallah B\r\nTen Cate H\r\nStehouwer C\r\nSpaetgens B","article_author_email":"Author email could not be found.","journal":"Thrombosis research","abstract":"Hypercoagulability is a major contributor to COVID-19 related pulmonary complications\r\nCommonly used approaches may be insufficient to ameliorate the risk of thromboembolic events in patients with COVID-19\r\nEven when on thromboprophylaxis, it is crucial to remain vigilant for the occurrence of VTE in patients with COVID-19.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":null,"country_contracted":"Netherlands","country_treated":"Netherlands","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":true,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"peripheral arterial disease","pregnant":false,"unknown":false,"site_of_disease":"lungs","clinical_syndrome":"pneumonia, respiratory tract infection, pulmonary embolism","severity":"ICU/Critical Care","prev_treatment":"","unusual":"Arterial and venous thromboembolic disease in a patient with COVID-19","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"While the patient was still on treatment","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"This patient has a history of peripheral arterial disease. This patient received oxygen via nasal cannula, and prophylactic low molecular weigh heparin. They also received IV rt-PA and after 24 h clopidogrel initiated for secondary stroke prevention. CT pulmonary angiography revealed pulmonary embolism in the right pulmonary artery and bilateral (sub)segmental pulmonary embolism were found. CT-imaging of the brain (including CT-angiography and CT-perfusion) showed no brain haemorrhage or arterial occlusion, yet a defect right frontal with large mismatch between perfusion and vascular volume recordings, indicative of right frontal lobe infarction, was seen.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,6772,6964,9229,10749,11408]}]